Philip Ward

[email protected]

AuntMinnieEurope.com Women's Imaging Insider

October 24, 2023

Dutch seek to optimize workflow for high-throughput breast MRI

Making relatively minor changes in the breast MRI workflow and facility design can help to increase patient throughput, a research group from Radboud University Medical Center in Nijmegen reported at the recent European Society of Breast Imaging annual meeting.

October 24, 2023

Week in Review: Lung screening advances | Breast implant ruptures | How to deliver value-based radiology

October 19, 2023

ESR's Carlo Catalano casts light on value-based radiology at JFR 2023

What does value-based radiology mean and how can it be achieved in practice? European Society of Radiology (ESR) President Prof. Carlo Catalano addressed this burning question during a special session at France's national radiology congress, JFR 2023.

October 16, 2023

Week in Review: JFR opens in Paris | Protocols in prostate MRI | Gadolinium retention

October 12, 2023

What can Europe learn from Canada on interventional training?

Training in interventional radiology (IR), as well as the cost-effectiveness of IR, is coming under intense scrutiny at France's national congress, JFR 2023. The Canadian approach to IR training is seen by many as a successful and viable model for Europeans to emulate.

October 12, 2023

MRI safety: What's the latest thinking on gadolinium retention?

Ten years have passed since gadolinium retention in the brain was first described. To mark the anniversary, European MRI experts have reflected on the background and the current state of knowledge about the use of gadolinium-based contrast agents.

October 9, 2023

Week in Review: Radiology's image problem? | Up close and personal with JFR 2023 president | Doubts cast over AI

October 5, 2023

Doubts cast over clinical use of AI to analyze chest x-rays

Commercially available chest x-ray algorithms require more research, an influential government-backed U.K. health technology agency has recommended. AI developers must conduct prospective studies to address gaps in evidence, it says.

October 2, 2023

Prof. Fergus Gleeson is one of four U.K. radiologists on the specialist committee for the NICE report. Photo courtesy of National Consortium of Intelligent Medical Imaging.

Week in Review: Radiologists outperform AI | Autopsy findings fuel debate | Imaging of immunotherapy complications

September 28, 2023

Page 2 of 189

Isotopes1

Telix signs agreement to acquire ITM

The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.

Screenshot 2026 09 21 202952

Sustainability in cancer care: from machines to systems

Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.

Les patients d’abord! Patients first at this year’s JFR meeting

Whats App Image 2026 09 17 At 15 24 59

IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?

From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.

Radiation medicine aims to tackle cancer care inequalities in low-income countries

ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda

By Claudia Tschabuschnig

From dental MRI to imaging after cancer treatment, ESHNR 2026 brings practical challenges and emerging techniques to Budapest on September 10–12. Here’s what to watch for.

September 9, 2026

Eshnr 26 Promo Ppt Reg Now 1920x1080 V1 Red

CIRSE: Patient selection drives local treatment of lung tumours

By Claudia Tschabuschnig

Billed as a controversy session, a discussion of local treatments for lung tumors at CIRSE 2026 highlighted common ground: patient selection, lung preservation, and the complementary roles of radiotherapy and ablation.

September 8, 2026

20260905 081521 Art6424 Scaled

Video: Charles Kahn on keeping pace with radiology AI

By Claudia Tschabuschnig

Dr. Charles Kahn looks beyond the AI hype to examine scientific rigor, better publishing, and what comes next.

September 7, 2026

Attack severely damages diagnostic imaging center in Odesa

By Claudia Tschabuschnig

After its facility was hit on 2 September, Innova Diagnostica is assessing whether its MRI scanner can be saved and working to restore specialized imaging services.

September 4, 2026

The exterior of Innova Diagnostica shows shattered windows, exposed wiring, damaged air-conditioning units, and debris surrounding the building. Several ground-floor windows have been boarded up. A message painted on the facade reads, “They destroy the future. We help bring it to life.”

MRI-based model shows changes over time in multiple myeloma patients

By Amerigo Allegretto

Whole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.

September 4, 2026

Multiple Myeloma 400

What should we teach radiology residents now that the algorithm reads too?

By Dr. Filippo Pesapane

In a new column, Dr. Filippo Pesapane of the European Institute of Oncology (IEO) IRCCS in Italy reflects on the important lessons learned about breast imaging AI technology and how they should impact radiologist training.

September 4, 2026

Filippo Pesapane

MRI shows how hormones affect mood

By Amerigo Allegretto

MRI scans show how higher progesterone levels indicate lower mood.

September 2, 2026

Woman Mother Stressed 400

What to watch for at CIRSE 2026

By Claudia Tschabuschnig

The program spans new treatments, clinical practice, training, and access to IR across Europe.

September 2, 2026

Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets

By Claudia Tschabuschnig

Prof. Ken Herrmann discusses the expansion of radioligand therapy into earlier treatment lines, the need for new cancer targets, long-term safety, and the challenge of translating innovation into robust clinical evidence.

September 1, 2026

Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen, pictured fourth from the left, at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.

AI cuts chest CT reporting time

Exploratory modeling suggested an approximate reduction of 0.5 full-time equivalent radiologist workload.

September 1, 2026

Example of AI-assisted pulmonary nodule detection and longitudinal volumetric assessment in a 65-year-old woman with peripheral arterial disease, a 24-pack-year smoking history, emphysema, and a family history of lung cancer. An incidental 8.5-mm right lower lobe pulmonary nodule is identified at CT angiography of the abdomen in July 2022 but does not receive follow-up. Subsequent imaging demonstrates interval growth, and CT-guided biopsy confirms stage IA lung adenocarcinoma. Contrast-enhanced axial chest CT images obtained on February 2, 2024, before robotic-assisted thoracoscopic segmentectomy, show a 12.1-mm spiculated right lower lobe pulmonary nodule. (A) Conventional contrast-enhanced axial chest CT image without AI assistance shows a 12.1-mm spiculated right lower lobe pulmonary nodule. (B) Corresponding CT image with AI-assisted pulmonary nodule detection, automated segmentation, and quantitative nodule assessment identifies a solid pulmonary nodule (nodule #1) measuring 13 × 8 (11) mm, with a volume of 739 mm3, a 45% volumetric increase compared with the previous contrast-enhanced chest CT performed on October 9, 2023 (510 mm3), and an estimated volume doubling time (VDT) of 216 days. (C) AI-generated longitudinal nodule analysis displays automated segmentation of the current (February 2, 2024) and previous (October 9, 2023) CT examinations, 3D nodule reconstruction, and quantitative volumetric assessment for longitudinal follow-up. The AI interface is displayed in the original software language (Dutch).

Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study

Overall sensitivity was 94% (95% CI, 85% to 98%) and specificity was 86% (95% CI, 77% to 92%).

August 31, 2026

This figure shows fused I-124 evuzamitide positron emission tomography (PET)/computed tomography (CT) images from patients without amyloidosis and from patients with ATTR cardiac amyloidosis, early ATTR cardiac amyloidosis, light chain cardiac amyloidosis, gelsolin-mediated amyloidosis, and systemic organ amyloid. The columns represent radiological transaxial, sagittal, and coronal views except for the last row middle and far right columns, which are coronal projections. The blue asterisks represent physiological activity (tracer activity in the stomach and esophagus). The arrowheads represent pathological uptake. Note the small amount of cardiac uptake in the basal septum and the basal lateral walls (likely early ATTR cardiac amyloidosis), splenic uptake and pleural uptake in light chain amyloidosis, and cardiac and kidney uptake in gelsolin-mediated amyloidosis. The bright yellow color represents more tracer uptake.

Video: Ken Herrmann maps nuclear medicine’s next frontiers

By Claudia Tschabuschnig

From earlier PSMA-targeted therapy and new cancer targets to total-body PET and low-dose screening, Prof. Ken Herrmann outlines where nuclear medicine could go next.

August 31, 2026

Page 2 of 92